{"title":"FDA Designates MM120 (LSD) Breakthrough Therapy for Generalized Anxiety Disorder","link":"https://www.businesswire.com/news/home/20240307733599/en/MindMed-Receives-FDA-Breakthrough-Therapy-Designation-and-Announces-Positive-12-Week-Durability-Data-From-Phase-2B-Study-of-MM120-for-Generalized-Anxiety-Disorder","date":1710004784000,"content":"<a href=\"https://news.ycombinator.com/item?id=39653125\">Comments</a>","author":"","siteTitle":"Hacker News","siteHash":"37bb545430005dba450c1e40307450d8e4e791b434e83f3d38915ebad510fd50","entryHash":"ef151d2f1ee1dd1af37494217494031013d484ca6759fd99d55d059e4e36e0a5","category":"Tech"}